Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

MOP & Operating Policies

 

Network Directory

 

Email Alias Lists

 

Bibliography

 

Training

 

Budget Guidance

 

Regulatory Resources

 

QA/QC Corner

 

Network Evaluation

 

Human Subject Protection Resources

 

Meeting & Call Minutes

 

Meeting & Call Calendars

 

Newsletter

 

Network Reports

 

Public Data Sets

 

Network Templates

 

Acronym List

 

Other Links


HPTN Annual Meeting 2008
Presentations

Presentations are available in pdf format only.  Click on a hyperlinked title to view or download individual presentations.  Presenters and authors retain copyright over these materials and requests for use should be directed accordingly.

Sunday April 6, 2008

 

Session: Orientation to the HIV Prevention Trials Network: Processes and Structures 

 

 

Introduction to the HPTN and the Coordinating and Operations Center (CORE)

 

Niru Sista

 

Introduction to the Statistical Data Management Center at SCHARP

 

Lynda Emel

 

Introduction to the HPTN Network Lab

 

Estelle Piwowar-Manning

 

HPTN Manual of Operations & Operating Policies

Michelle Immelman

Monday April 7, 2008

 

Session I: Opening Session (joint session with IMPAACT)

 

 

HIV/AIDS in 2008: Challenges and What's Ahead

 

Carl Dieffenbach

 

HPTN 039: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High-Risk HSV-2 Seropositive, HIV Seronegative Persons

Jim Hughes

     
 

Session II: State of the Networks (joint session with IMPAACT) 

 

 

HPTN State of the Network

 

Sten Vermund

 

IMPAACT State of the Network

 

Brooks Jackson

     
 

Session III: Key Trial Achievements (joint session with IMPAACT)

 

 

Challenges and Unanswered Questions in a Randomized Controlled Trial of Diaphragms and Gel to Prevent HIV (the MIRA trial)

 

Nancy Padian

 

Lessons Learned from the STEP and Phambili Vaccine Trials

 

Susan Buchbinder

 

The Closing of CONRAD'S Cellulose Sulfate HIV Prevention Trial

 

Lut Van Damme

 

Carraguard® Phase 3 Lessons Learned

 

Robin Maguire

 

Extended-Dose Nevirapine to Six Weeks of Age for Infants in Ethiopia, India and Uganda: A Randomized Trial for Prevention of HIV Transmission to Breastfed Infants (SWEN)

 

Bob Bollinger

 

Extended Infant Post-Exposure Prophylaxis with Antiretroviral Drugs Reduces Postnatal HIV Transmission: PEPI-Malawi (unavailable)

 

Taha Taha

 

Session IV: DAIDS Roles and Responsibilities (joint session with IMPAACT)

 

 

Grants Management Panel

Ed Handlesman; Leslie Norwood; Judi Miller; Donna Germuga

 

Session V: HPTN Trials

 

 
 

Design Challenges in HIV Prevention Trials

 

Jim Hughes

 

Ethics Presentation (unavailable)

 

Jeremy Sugarman

 

Community Engagement in HIV Prevention Trials

 

Janet Frohlich; Julie Davids

 

HPTN 061: A Feasibility Study of a Community-Level, Multi-Component Intervention for Black Men Who Have Sex with Men

 

Ken Mayer

 

HPTN 062P & 062: An Individual-Level Prevention Intervention for Individuals with Acute HIV Infection

 

Audrey Pettifor

 

HPTN 063: Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings

 

Steve Safren

 

HPTN 064: The Women's HIV Seroincidence Study (ISIS) (unavailable)

Sally Hodder

Tuesday April 8, 2008

 

Session: HPTN Network Laboratory Plenary

 

 

HPTN Network Laboratory Update

 

Susan Eshleman

 

HIV Cross Sectional Incidence Testing

 

Oliver Laeyendecker

 

Herpes and HIV Co-Infections: Diagnostic Dilemmas in Clinical Trials

 

Thomas Quinn

      
 

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: April 14, 2008